Following the successful conclusion of the ENDO 2026 annual meeting in Chicago, the Endocrine Society has announced a robust schedule of specialized programming for the fall season, targeting both fundamental research and clinical application. The upcoming calendar represents a strategic pivot from large-scale general assemblies toward focused, high-intensity symposia designed to address specific gaps in endocrinology, including oncological immunology, nuclear receptor biology, and rigorous certification standards for practitioners. This diverse array of programming underscores the Society’s commitment to advancing hormone science and improving patient outcomes through a dual-track approach that serves basic scientists and medical clinicians alike.
Strategic Collaboration: The Keystone Symposia Partnership
A primary highlight of the fall schedule is the inaugural meeting of a new collaborative series between the Endocrine Society and Keystone Symposia. Titled "Hormonal Influences on Immunity and Cancer Across the Lifespan," the event is scheduled to take place in person from October 5 to October 8 in Breckenridge, Colorado. This partnership marks a significant milestone in interdisciplinary research, merging the Endocrine Society’s expertise in hormonal signaling with Keystone’s reputation for hosting intimate, discovery-driven scientific conferences.
The Breckenridge meeting aims to facilitate a "bench-to-bedside-and-back" dialogue, a framework that emphasizes the translation of laboratory findings into clinical trials and the subsequent return of clinical data to basic researchers for further refinement. The integrated focus on hormones and immunity addresses an emerging frontier in oncology, as researchers increasingly recognize the role of the endocrine system in modulating the immune microenvironment within tumors. By examining these influences across the lifespan—from pediatric development to geriatric health—the symposium seeks to identify unique therapeutic windows and personalized treatment strategies for cancer patients.
Organizers have noted that the intimate setting is intentionally designed to foster high-level networking and collaboration among translational researchers. The goal is to move beyond siloed investigations and create a unified platform where foundational science can lead to breakthroughs in immunotherapy and hormonal modulation of malignant growths.
Global Perspectives on Aging: The Science Summit in Málaga
In late September, the Society will shift its focus to the European scientific community with the "Science Summit – Networked for Life: Nuclear Receptors in Age-related Diseases." Hosted in Málaga, Spain, from September 21 to 23, this summit serves as an international forum for the study of nuclear receptors, a class of proteins found within cells that are responsible for sensing steroid and thyroid hormones and certain other molecules.
Nuclear receptors play a critical role in regulating gene expression, making them vital targets for drug development in the treatment of age-related conditions, including osteoporosis, cardiovascular disease, and neurodegenerative disorders. The summit is chaired by prominent figures in the field, including Inés Pineda-Torra of CABIMER and Mercedes Ricote of CNB-CSIC, building upon a legacy of high-impact events focused on molecular mechanisms.
The Málaga summit will feature a global roster of innovators who will present the latest discoveries in basic molecular biology and emerging therapeutic applications. As the global population continues to age, the demand for medical interventions that address the underlying biological drivers of senescence has increased. This meeting is positioned to provide the scientific community with the tools necessary to influence health and disease trajectories across the lifespan through the manipulation of nuclear receptor pathways.
Rigorous Certification Support: The Endocrine Board Review 2026
For the clinical community, the Society is prioritizing professional certification through the Endocrine Board Review (EBR) 2026. Scheduled as an online event from September 18 to September 20, the EBR is a long-standing program tailored specifically for rising endocrinologists preparing for the American Board of Internal Medicine (ABIM) Endocrinology, Diabetes, and Metabolism board exam.
The ABIM endocrinology exam is widely recognized as one of the most intellectually demanding assessments in the medical field. Industry data suggests that even highly competent candidates can struggle without a structured approach to the vast curriculum required for mastery. To address this, the EBR program employs a methodical structure that includes the 18th edition of the Endocrine Board Review book and customizable online practice exams.
A unique feature of the 2026 program is the Society’s "pass guarantee." Under this policy, participants who complete the 2026 EBR program but do not pass the ABIM exam are offered free registration for the 2027 certification cycle. This initiative reflects the Society’s confidence in its pedagogical approach and its commitment to ensuring a pipeline of qualified specialists to meet the growing demand for endocrine care. The live study sessions in September will specifically target "commonly missed topics," providing a final, focused review before the official examination dates.
Clinical Excellence and Continuing Education: The CEU 2026
Rounding out the fall educational programming is the Clinical Endocrinology Update (CEU) 2026, which will take place virtually from October 22 to October 24. While the EBR is focused on initial certification, the CEU is designed for practicing clinicians who must stay current with rapidly evolving guidelines and emerging therapies.
The three-day program provides a comprehensive review of the latest evidence in diabetes management, metabolism, and general endocrinology. Participants are encouraged to engage in case discussions that mirror the challenges they face in daily practice. The 2026 curriculum is designed to be highly interactive, allowing for the exploration of new clinical data and the practical application of evolving medical standards.
The CEU also serves as a vital source of Continuing Medical Education (CME) credits. Participants can earn up to 18 AMA PRA Category 1 Credits™ and 18 ABIM Maintenance of Certification (MOC) points. Furthermore, members who access the post-event recordings can earn up to an additional 36 credits, totaling a significant portion of the annual requirements for medical licensure and professional standing.
Chronology of Major Events: Fall 2026
The Endocrine Society’s fall calendar is structured to provide continuous engagement for its members over a two-month period:
- September 18–20: Endocrine Board Review (EBR) 2026 (Virtual) – Focused on board exam preparation and certification.
- September 21–23: Science Summit (Málaga, Spain) – Focused on nuclear receptors and age-related disease research.
- October 5–8: Keystone Meeting (Breckenridge, CO) – Focused on the intersection of hormones, immunity, and cancer.
- October 22–24: Clinical Endocrinology Update (CEU) 2026 (Virtual) – Focused on clinical guidelines and continuing medical education.
This timeline reflects a strategic distribution of events, allowing professionals to participate in multiple sessions without significant overlap, while also providing geographical and digital accessibility.
Broader Implications for Public Health and Research Innovation
The expansion of the Endocrine Society’s fall programming comes at a time when endocrine-related health issues are reaching record levels globally. According to the Centers for Disease Control and Prevention (CDC), more than 38 million Americans have diabetes, and the prevalence of obesity and thyroid disorders continues to rise. These trends necessitate a medical workforce that is not only highly trained but also updated on the latest therapeutic innovations.
By hosting specialized meetings like the Keystone collaboration and the Málaga Science Summit, the Society is directly addressing the need for translational research. The transition from "bench to bedside" is often cited as the most difficult phase of medical innovation; however, by providing a dedicated space for basic scientists and clinicians to interact, the Society accelerates the timeline for bringing new treatments to market.
Furthermore, the emphasis on age-related diseases reflects a shift in global healthcare priorities. As life expectancy increases, the burden of chronic disease grows. Research into nuclear receptors offers a path toward "healthy aging," where the focus is not just on extending life, but on maintaining physiological function and quality of life through hormonal balance.
The Society’s Center for Learning and its various Special Interest Groups (SIGs) complement these major meetings by providing year-round webinars and niche courses. This ecosystem of learning ensures that the Endocrine Society remains the central hub for hormone research and clinical practice, maintaining high standards of excellence across the profession.
Official Outlook and Future Directions
In statements regarding the upcoming fall lineup, Society representatives emphasized that these meetings are "best in class," offering unparalleled opportunities to interact with the "leading lights" of the profession. The shift toward hybrid and virtual models for the EBR and CEU programs highlights an awareness of the logistical challenges facing modern clinicians, while the in-person symposia in Colorado and Spain acknowledge the irreplaceable value of face-to-face scientific exchange.
As the field of endocrinology becomes increasingly integrated with other disciplines—such as oncology, immunology, and gerontology—the Endocrine Society’s role as an interdisciplinary coordinator becomes more vital. The 2026 fall lineup is a testament to this evolution, moving beyond traditional boundaries to address the most pressing scientific and clinical questions of the decade. Professionals and researchers are encouraged to register through the Society’s official portal to secure their participation in these pivotal events.
